Bio Green Med Solution, Inc. (BGMS): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$848.0K
Year ended 2025-12-31
-65.3%
3-year compound annual growth
$20.27M2009-12-31: $9.77M2010-12-31: $6.41M2011-12-31: $9.21M2012-12-31: $6.59M2013-12-31: $11.28M2014-12-31: $18.28M2015-12-31: $12.38M2016-12-31: $9.48M2017-12-31: $4.24M2018-12-31: $4.33M2019-12-31: $4.66M2020-12-31: $4.76M2021-12-31: $14.93M2022-12-31: $20.27M2023-12-31: $19.16M2024-12-31: $6.66M2025-12-31: $848.0K$848.0K
2009-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$848.0K-87.3%2026-03-30, From 2025-01-01
2024-12-31$6.66M-65.3%2026-03-30, From 2024-01-01
2023-12-31$19.16M-5.5%2025-11-26, From 2023-01-01
2022-12-31$20.27M+35.8%2024-03-21, From 2022-01-01
2021-12-31$14.93Mn/c2023-11-29, From 2021-01-01
2020-12-31$4.76M+2.2%2022-03-30, From 2020-01-01
2019-12-31$4.66M+7.6%2021-03-01, From 2019-01-01
2018-12-31$4.33M+2.1%2020-03-05, From 2018-01-01
2017-12-31$4.24M-55.3%2019-03-28, From 2017-01-01
2016-12-31$9.48M-23.5%2018-03-30, From 2016-01-01
2015-12-31$12.38M-32.3%2017-03-31, From 2015-01-01
2014-12-31$18.28M+62.1%2016-03-29, From 2014-01-01
2013-12-31$11.28M+71.1%2015-03-31, From 2013-01-01
2012-12-31$6.59M-28.4%2014-03-26, From 2012-01-01
2011-12-31$9.21M+43.5%2014-03-26, From 2011-01-01
2010-12-31$6.41M-34.3%2013-04-01, From 2010-01-01
2009-12-31$9.77Mn/a2012-03-30, From 2009-01-01